CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial

OBJECTIVE: The aim of this prospective, single-arm phase II trial was to confirm the safety and efficacy of neoadjuvant chemotherapy (NAC) using oxaliplatin plus capecitabine (CapOX) for patients with operable locally advanced colon cancer (CC). METHODS: Patients with computed tomography-defined T4...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fangqi, Yang, Li, Wu, Yuchen, Li, Cong, Zhao, Jiang, Keranmu, Adili, Zheng, Hongtu, Huang, Dan, Wang, Lei, Tong, Tong, Xu, Junyan, Zhu, Ji, Cai, Sanjun, Xu, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242445/
https://www.ncbi.nlm.nih.gov/pubmed/28174487
http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242445/
https://www.ncbi.nlm.nih.gov/pubmed/28174487
http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.05

Ejemplares similares